Reporter Describes Inner Circle Visit to Stonehenge at Sunset
A Sydney-based reporter joined a paid after-hours tour at the Neolithic monument. The group entered the stone circle near dusk and observed the site under changing light.
sbs.com.auA reporter traveling from Australia chose the Inner Circle tour at Stonehenge to gain closer access to the monument. The visit occurred near dusk on a grey, chilly afternoon after the site had closed to the general public. Guides from English Heritage led the small group past a rope barrier and into the ring of stones.
From inside the circle, the reporter viewed each stone from multiple angles during the allotted half-hour period. As the time ended, sunlight broke through the clouds and lit the stones in golden light while casting long shadows. The reporter noted that the monument appears different when approached on foot rather than viewed from the adjacent highway.
The account states that Stonehenge functions as a temple, burial site, and ancient calendar, yet researchers still have limited understanding of its original purpose. The writer concluded that the site should be experienced directly rather than observed from a passing vehicle.
Key Facts
Story Timeline
3 events- Afternoon of visit
Reporter joined Inner Circle tour after site closed to public.
1 source@NewScientist - During visit
Group entered stone circle and viewed each stone from multiple angles.
1 source@NewScientist - End of visit
Sunlight illuminated the stones as the allotted time concluded.
1 source@NewScientist
Potential Impact
- 01
Visitors may choose paid tours for closer monument access.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…